UPB Competitors & Alternatives
Compare Upstream Bio, Inc. with similar stocks in the same industry
Biotechnology
UPB
Main Stock$6.42
Tradestie Score
47
Market Cap
$1.00B
Revenue Growth
0.8%
Analyst Upside
+495.8%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DSGN
Design Therapeutics, Inc. Common Stock
|
$12.76
|
$386.68M | - | 52 | Compare |
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.04
|
$382.04M | - | 51 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$11.92
|
$371.64M | - | 58 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$16.25
|
$354.45M | - | 55 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$42.84
|
$353.70M | - | 54 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.00
|
$341.56M | - | 47 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.25
|
$332.96M | - | 51 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.91
|
$328.62M | - | 47 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.93
|
$308.74M | - | 54 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$10.07
|
$304.12M | - | 59 | Compare |
More UPB Analysis
Data updated: Aug 04, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry